Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1999 Apr;80(4):343–347. doi: 10.1136/adc.80.4.343

Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing

G Fox 1, M Everard 1, M Marsh 1, A Milner 1
PMCID: PMC1717884  PMID: 10086941

Abstract

BACKGROUND—Previous studies suggest that recurrent episodes of coughing and wheezing occur in up to 75% of infants after acute viral bronchiolitis.
AIM—To assess the efficacy of budesonide given by means of a metered dose inhaler, spacer, and face mask in reducing the incidence of coughing and wheezing episodes up to 12 months after acute viral bronchiolitis.
METHODS—Children under the age of 12 months admitted to hospital with acute viral bronchiolitis were randomised to receive either budesonide or placebo (200 µg or one puff twice daily) for the next eight weeks. Parents kept a diary card record of all episodes of coughing and wheezing over the next 12months.
RESULTS—Full follow up data were collected for 49 infants. There were no significant differences between the two study groups for the number of infants with symptom episodes up to six months after hospital discharge. At 12 months, 21 infants in the budesonide group had symptom episodes compared with 12 of 24 in the placebo group. The median number of symptom episodes was 2 (range, 0-13) in those who received budesonide and 1 (range, 0-11) in those who received placebo. Because there is no pharmacological explanation for these results, they are likely to be caused by a type 1 error, possibly exacerbated by there being more boys in the treatment group.
CONCLUSION—Routine administration of budesonide by means of a metered dose inhaler, spacer, and face mask system immediately after acute viral bronchiolitis cannot be recommended.



Full Text

The Full Text of this article is available as a PDF (126.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer L. N., Simpson H. Night cough counts and diary card scores in asthma. Arch Dis Child. 1985 May;60(5):473–474. doi: 10.1136/adc.60.5.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brooks L. J., Cropp G. J. Theophylline therapy in bronchiolitis. A retrospective study. Am J Dis Child. 1981 Oct;135(10):934–936. doi: 10.1001/archpedi.1981.02130340040014. [DOI] [PubMed] [Google Scholar]
  3. Carlsen K. H., Larsen S., Bjerve O., Leegaard J. Acute bronchiolitis: predisposing factors and characterization of infants at risk. Pediatr Pulmonol. 1987 May-Jun;3(3):153–160. doi: 10.1002/ppul.1950030308. [DOI] [PubMed] [Google Scholar]
  4. Carlsen K. H., Larsen S., Orstavik I. Acute bronchiolitis in infancy. The relationship to later recurrent obstructive airways disease. Eur J Respir Dis. 1987 Feb;70(2):86–92. [PubMed] [Google Scholar]
  5. Carlsen K. H., Leegaard J., Larsen S., Orstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child. 1988 Dec;63(12):1428–1433. doi: 10.1136/adc.63.12.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Connolly J. H., Field C. M., Glasgow J. F., Slattery C. M., MacLynn D. M. A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta Paediatr Scand. 1969 Mar;58(2):116–120. doi: 10.1111/j.1651-2227.1969.tb04693.x. [DOI] [PubMed] [Google Scholar]
  7. Dabbous I. A., Tkachyk J. S., Stamm S. J. A double blind study on the effects of corticosteroids in the treatment of bronchiolitis. Pediatrics. 1966 Mar;37(3):477–484. [PubMed] [Google Scholar]
  8. De Boeck K., Van der Aa N., Van Lierde S., Corbeel L., Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. J Pediatr. 1997 Dec;131(6):919–921. doi: 10.1016/s0022-3476(97)70044-1. [DOI] [PubMed] [Google Scholar]
  9. Duiverman E. J., Neijens H. J., van Strik R., Affourtit M. J., Kerrebijn K. F. Lung function and bronchial responsiveness in children who had infantile bronchiolitis. Pediatr Pulmonol. 1987 Jan-Feb;3(1):38–44. doi: 10.1002/ppul.1950030111. [DOI] [PubMed] [Google Scholar]
  10. Gurwitz D., Mindorff C., Levison H. Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J Pediatr. 1981 Apr;98(4):551–555. doi: 10.1016/s0022-3476(81)80758-5. [DOI] [PubMed] [Google Scholar]
  11. Hall C. B., McBride J. T., Gala C. L., Hildreth S. W., Schnabel K. C. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA. 1985 Dec 6;254(21):3047–3051. [PubMed] [Google Scholar]
  12. Hall C. B., McBride J. T., Walsh E. E., Bell D. M., Gala C. L., Hildreth S., Ten Eyck L. G., Hall W. J. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med. 1983 Jun 16;308(24):1443–1447. doi: 10.1056/NEJM198306163082403. [DOI] [PubMed] [Google Scholar]
  13. Hampton J. R. Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials. Br Med J (Clin Res Ed) 1982 Jul 3;285(6334):33–36. doi: 10.1136/bmj.285.6334.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Henry R. L., Hodges I. G., Milner A. D., Stokes G. M. Respiratory problems 2 years after acute bronchiolitis in infancy. Arch Dis Child. 1983 Sep;58(9):713–716. doi: 10.1136/adc.58.9.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Holberg C. J., Wright A. L., Martinez F. D., Ray C. G., Taussig L. M., Lebowitz M. D. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol. 1991 Jun 1;133(11):1135–1151. doi: 10.1093/oxfordjournals.aje.a115826. [DOI] [PubMed] [Google Scholar]
  16. Kellner J. D., Ohlsson A., Gadomski A. M., Wang E. E. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med. 1996 Nov;150(11):1166–1172. doi: 10.1001/archpedi.1996.02170360056009. [DOI] [PubMed] [Google Scholar]
  17. Korppi M., Reijonen T., Pöysä L., Juntunen-Backman K. A 2- to 3-year outcome after bronchiolitis. Am J Dis Child. 1993 Jun;147(6):628–631. doi: 10.1001/archpedi.1993.02160300034017. [DOI] [PubMed] [Google Scholar]
  18. Leer J. A., Jr, Green J. L., Heimlich E. M., Hyde J. S., Moffet H. L., Young G. A., Barron B. A. Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children. Am J Dis Child. 1969 May;117(5):495–503. [PubMed] [Google Scholar]
  19. Maayan C., Itzhaki T., Bar-Yishay E., Gross S., Tal A., Godfrey S. The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate. Pediatr Pulmonol. 1986 Jan-Feb;2(1):9–14. doi: 10.1002/ppul.1950020106. [DOI] [PubMed] [Google Scholar]
  20. McConnochie K. M., Roghmann K. J. Bronchiolitis as a possible cause of wheezing in childhood: new evidence. Pediatrics. 1984 Jul;74(1):1–10. [PubMed] [Google Scholar]
  21. McConnochie K. M., Roghmann K. J. Wheezing at 8 and 13 years: changing importance of bronchiolitis and passive smoking. Pediatr Pulmonol. 1989;6(3):138–146. doi: 10.1002/ppul.1950060303. [DOI] [PubMed] [Google Scholar]
  22. Mok J. Y., Simpson H. Symptoms, atopy, and bronchial reactivity after lower respiratory infection in infancy. Arch Dis Child. 1984 Apr;59(4):299–305. doi: 10.1136/adc.59.4.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Murray M., Webb M. S., O'Callaghan C., Swarbrick A. S., Milner A. D. Respiratory status and allergy after bronchiolitis. Arch Dis Child. 1992 Apr;67(4):482–487. doi: 10.1136/adc.67.4.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Noble V., Ruggins N. R., Everard M. L., Milner A. D. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child. 1992 Mar;67(3):285–288. doi: 10.1136/adc.67.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. O'Callaghan C., Milner A. D., Swarbrick A. Spacer device with face mask attachment for giving bronchodilators to infants with asthma. BMJ. 1989 Jan 21;298(6667):160–161. doi: 10.1136/bmj.298.6667.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. O'Callaghan C. Particle size of beclomethasone dipropionate produced by two nebulisers and two spacing devices. Thorax. 1990 Feb;45(2):109–111. doi: 10.1136/thx.45.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Osundwa V. M., Dawod S. T., Ehlayel M. Recurrent wheezing in children with respiratory syncytial virus (RSV) bronchiolitis in Qatar. Eur J Pediatr. 1993 Dec;152(12):1001–1003. doi: 10.1007/BF01957225. [DOI] [PubMed] [Google Scholar]
  28. Pullan C. R., Hey E. N. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed) 1982 Jun 5;284(6330):1665–1669. doi: 10.1136/bmj.284.6330.1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Randolph A. G., Wang E. E. Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview. Arch Pediatr Adolesc Med. 1996 Sep;150(9):942–947. doi: 10.1001/archpedi.1996.02170340056011. [DOI] [PubMed] [Google Scholar]
  30. Reijonen T., Korppi M., Kuikka L., Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med. 1996 May;150(5):512–517. doi: 10.1001/archpedi.1996.02170300066013. [DOI] [PubMed] [Google Scholar]
  31. Rooney J. C., Williams H. E. The relationship between proved viral bronchiolitis and subsequent wheezing. J Pediatr. 1971 Nov;79(5):744–747. doi: 10.1016/s0022-3476(71)80385-2. [DOI] [PubMed] [Google Scholar]
  32. Roosevelt G., Sheehan K., Grupp-Phelan J., Tanz R. R., Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet. 1996 Aug 3;348(9023):292–295. doi: 10.1016/s0140-6736(96)02285-4. [DOI] [PubMed] [Google Scholar]
  33. Rylander E., Eriksson M., Freyschuss U. Risk factors for occasional and recurrent wheezing after RSV infection in infancy. Acta Paediatr Scand. 1988 Sep;77(5):711–715. doi: 10.1111/j.1651-2227.1988.tb10735.x. [DOI] [PubMed] [Google Scholar]
  34. SUSSMAN S., GROSSMAN M., MAGOFFIN R., SCHIEBLE J. DEXAMETHASONE (16-ALPHA-METHYL, 9-ALPHA-FLUOROPREDNISOLONE) IN OBSTRUCTIVE RESPIRATORY TRACT INFECTIONS IN CHILDREN. A CONTROLLED STUDY. Pediatrics. 1964 Dec;34:851–855. [PubMed] [Google Scholar]
  35. Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B., Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995 Apr;95(4):500–505. [PubMed] [Google Scholar]
  36. Sims D. G., Downham M. A., Gardner P. S., Webb J. K., Weightman D. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J. 1978 Jan 7;1(6104):11–14. doi: 10.1136/bmj.1.6104.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sly P. D., Hibbert M. E. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy. Pediatr Pulmonol. 1989;7(3):153–158. doi: 10.1002/ppul.1950070307. [DOI] [PubMed] [Google Scholar]
  38. Springer C., Bar-Yishay E., Uwayyed K., Avital A., Vilozni D., Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol. 1990;9(3):181–185. doi: 10.1002/ppul.1950090311. [DOI] [PubMed] [Google Scholar]
  39. Taber L. H., Knight V., Gilbert B. E., McClung H. W., Wilson S. Z., Norton H. J., Thurson J. M., Gordon W. H., Atmar R. L., Schlaudt W. R. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics. 1983 Nov;72(5):613–618. [PubMed] [Google Scholar]
  40. WITTIG H. J., GLASER J. The relationship between bronchiolitis and childhood asthma; a follow-up study of 100 cases of bronchiolitis. J Allergy. 1959 Jan-Feb;30(1):19–23. doi: 10.1016/0021-8707(59)90054-1. [DOI] [PubMed] [Google Scholar]
  41. Webb M. S., Henry R. L., Milner A. D., Stokes G. M., Swarbrick A. S. Continuing respiratory problems three and a half years after acute viral bronchiolitis. Arch Dis Child. 1985 Nov;60(11):1064–1067. doi: 10.1136/adc.60.11.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Webb M. S., Milner A. D., Hiller E. J., Henry R. L. Nebulised beclomethasone dipropionate suspension. Arch Dis Child. 1986 Nov;61(11):1108–1110. doi: 10.1136/adc.61.11.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zweiman B., Schoenwetter W. F., Pappano J. E., Jr, Tempest B., Hildreth E. A. Patterns of allergic respiratory disease in children with a past history of bronchiolitis. J Allergy Clin Immunol. 1971 Nov;48(5):283–289. doi: 10.1016/0091-6749(71)90029-7. [DOI] [PubMed] [Google Scholar]
  44. van Woensel J. B., Wolfs T. F., van Aalderen W. M., Brand P. L., Kimpen J. L. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax. 1997 Jul;52(7):634–637. doi: 10.1136/thx.52.7.634. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES